1,6-Nonadien-3-OL, 3,7-dimethyl-, acetate
Common Name: |
1,6-Nonadien-3-OL, 3,7-dimethyl-, acetate |
IUPAC Name: |
[(6E)-3,7-dimethylnona-1,6-dien-3-yl] acetate |
Molecular Formula: |
C13H22O2 |
SMILES: |
CCC(=CCCC(C)(C=C)OC(=O)C)C |
Inchi: |
1S/C13H22O2/c1-6-11(3)9-8-10-13(5,7-2)15-12(4)14/h7,9H,2,6,8,10H2,1,3-5H3/b11-9+ |
Inchi Key: |
IVSZEHYDOLAREK-PKNBQFBNSA-N |
Cas No: |
61931-80-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
210.31 |
Mass (g/mol) |
210.162 |
Molar Refractivity |
64.98 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
7 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
246.00 to 247.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.026 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
4.021 |
iLOGP |
3.41 |
XLOGP3 |
4.36 |
WLOGP |
3.63 |
MLOGP |
3.22 |
ESOL Log S |
-3.43 |
ESOL Solubility (mg/ml) |
0.078 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.63 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.92 |
Silicos-IT Solubility (mg/ml) |
0.25 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.49 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.607 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.212 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |